RetinAI Collaborates with Novartis to Provide AI Solutions in Ophthalmology
Shots:
- RetinAI signs a multi-year collaboration with Novartis under which RetinAI’s IT solutions and AI tools will be employed to support multiple projects in ophthalmology and digital health
- The first project under the agreement will support a multi-center international clinical study involving patients with nAMD. The study is designed to investigate the influence of OCT image solutions using AI on the assessment of disease activity
- The study will be conducted across multiple centers in numerous EU countries and Canada- involving 500+ patients. RetinaAI will provide its data management platform to efficiently process data at scale across imaging platforms and devices
Ref: RetinAI | Image: Novartis
Click here to read the full press release
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com